DsbA: A target for the design of drug candidates as selective inhibitors of oxidative protein folding in Gram-negative bacteria

  • Scanlon, Martin (Primary Chief Investigator (PCI))
  • Charman, William (Chief Investigator (CI))
  • Sakellaris, Haralambos (Chief Investigator (CI))
  • Farrell, Leigh (Partner Investigator (PI))

Project: Research

Project Details

StatusFinished
Effective start/end date3/02/05 → 1/02/07

Funding

  • Australian Research Council (ARC): A$104,450.00
  • GBS Ventures: A$90,000.00